ArticlePloS one2026
A multi-period robust portfolio optimization framework using yager's entropy.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Modern portfolio theory, while foundational, struggles with extreme sensitivity to input parameters and a tendency to select highly concentrated portfolios, often leading to out-of-sample underperformance. This research addresses these critical gaps by introducing the Generalized Robust Mean-Variance-Entropy (GRMVE) framework, a novel Mixed-Integer Quadratic Programming (MIQP) model designed for adaptive, multi-period investment settings. The GRMVE framework integrates budgeted uncertainty to mitigate the risk of estimation errors in expected returns, while simultaneously incorporating Yager's entropy to mathematically enforce structural diversification and prevent over-concentration. The framework is empirically validated using a dynamic, expanding-window re-optimization approach over a 72-month horizon on a pre-selected universe of 60 assets spanning all 11 sectors of the S&P 500. Out-of-sample results demonstrate that the GRMVE framework achieves highly competitive risk-adjusted returns compared to the famously resilient Naive (1/n) strategy and the state-of-the-art Mean-CVaR model. Crucially, it overcomes the severe portfolio concentration and prohibitive trading turnover associated with scenario-based tail-risk models (CVaR) and the extreme instability of non-robust mean-variance models. By successfully navigating severe market downturns and volatile recoveries with significantly lower drawdowns, the findings highlight the GRMVE framework as a highly practical, computationally tractable, and structurally resilient solution for institutional portfolio management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.